Skip to main content
logo
Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
13.92
+0.30 (2.20%)
Sep 1, 2026, 11:02 AM EDT - Market open

Summit Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
11,10513,48713,1601,829897263
Market Cap Growth
-36.92%2.49%619.43%103.94%241.23%-32.01%
Enterprise Value
10,43413,25412,7051,737779184
Last Close Price
13.6217.4917.842.614.252.69

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
----1272.24145.30
PB Ratio
17.1520.4733.8523.547.083.16
P/TBV Ratio
17.3020.5334.0224.137.183.71

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
----1105.42101.96

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.030.030.021.374.100.03
Net Debt / Equity Ratio
-1.06-1.05-1.04-1.031.34-0.83
Net Debt / EBITDA Ratio
0.770.631.920.91-2.730.81
Net Debt / FCF Ratio
1.462.142.851.04-4.030.95
Asset Turnover
----0.000.02
Quick Ratio
6.679.789.889.179.153.47
Current Ratio
6.969.8710.159.3016.933.80
Return on Equity (ROE)
-192.50%-206.10%-94.89%-601.85%-75.05%-108.89%
Return on Assets (ROA)
-101.61%-115.28%-41.30%-12.79%-10.23%-49.91%
Return on Capital Employed (ROCE)
-134.90%-161.40%-53.60%-48.60%-10.20%-98.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-7.88%-8.00%-1.68%-33.62%-8.78%-33.71%
FCF Yield
-4.23%-2.40%-1.08%-4.20%-4.71%-27.73%
Buyback Yield / Dilution
-4.03%-4.06%-15.96%-220.50%-109.60%-32.67%
SEC Filings: 10-K · 10-Q